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ABSTRACT 
Objective:  To determine about the incidence of infection and causative organisms in patients with Ventriculo-
peritoneal shunting for hydrocephalus. 
Materials and Methods:  This retrospective observational study was carried out in the Department of Neur-
osurgery Lady Reading Hospital Peshawar, from Jan 2012 to Dec 2013 (one year).The medical record of all 
cases operated in last one year was checked from record room. Documentation was done according to Performa 
designed indicating age, sex, clinical features and type of microorganism. All patients of either sex and age with 
Previous Ventriculoperitoneal shunt surgery and Signs and symptoms suggestive of shunt infection were included 
in the study. While patients of previous Ventriculoperitoneal shunt with no signs and symptoms were excluded 
from the study. All the data were analyzed by SPSS 20 and results were represented in the form of graphs / tables. 
Results:  Total 82 patients were included in the study in which males were 50 (60.97%) and females were 32 
(39.02%). All the patients were in the age range of 6 months to 75 years having mean age of 37.75 years ± 5 SD. 
58 (70.73%) were in pediatric age group and 24 (29.26%) were adults. Regarding etiology congenital acqui-
ductal stenosis was the leading cause in children’s having 22/58 (37.93%) and CNS tumors were the most 
common cause in adults having 10/24 (41.66%). Fever and vomiting were the most common mode of presentation 
with 66 (80%) cases. overall incidence of shunt infection was 12 (14.63%) in which the most common micro-
organism was coagulase negative staphylococci having 6/12 (50%) cases. 
Conclusion:  Shunt infection most commonly occur in children’s and coagulase negative staphylococci is the 
most common causative organism. 
Key Words:  Incidence, Infection, Ventriculoperitoneal shunting, Hydrocephalus, Coagulase negative staphy-
lococci. 
Abbreviations:  CSF: Cerebrospinal Fluid. 
 
INTRODUCTION 
Hydrocephalus is an enlargement of the ventricular 
system, which results from an imbalance between pro-
duction and absorption of cerebrospinal fluid (CSF) 
within the brain – CSF pathways.1 Ventriculoperito-
neal (VP) shunting of the cerebrospinal fluid (CSF) 
remains one of the most Important for treatment of 
patients with hydrocephalus.
2,3
 Shunt malfunction and 
Infection are two most common complications of VP 
shunt. Shunt infection is defined as isolation of the 
organism from the ventricular fluid (CSF), shunt tube, 
reservoir, or blood culture along with the clinical signs 
and symptoms suggestive of shunt infection or mal-
function like fever, peritonitis, meningitis, signs of 
infection along the shunt tract, or nonspecific signs 
and symptoms of headache, vomiting, change in men-
tal status, or seizures.
4
 In the literature, reported infect-
ion rates range from 3% to 27% among children imp-
lanted with a VP shunt before the age of 6 months.
5,6
 
Prematurity is also a risk factor for VP shunt infec-
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tions.
6
 
 While in adults The incidence of shunt-associated 
infection has a range of 1% – 18%7,8 and several inde-
pendent risk factors have been identified, including 
previous shunt – associated infection, shunt revision 
for dysfunction, postoperative CSF leakage, advanced 
age, duration of the shunt placement, experience of the 
neurosurgeon, and use of a neuroendoscope.
9,10
 In chil-
dren common organisms causing shunt infections are. 
Staphylococcus aureus and coagulase – negative Sta-
phylococcus species, a variety of gram – negative 
rods, Proprionibacterium species, and Enterococcus 
faecalis.
11-14
 While in adults, Staphylococcus aureus, 
coagulase negative Staphylococci, gram negative baci-
lli and polymicrobial organisms are common infective 
agents.
15
 Shunt infection is suspected when patient 
present with signs of meningitis, inflammation in the 
path of the catheter, malfunction of the system, symp-
toms such as abdominal pain, distension or the pre-
sence of intra-abdominal cyst.
16
 Other symptoms that 
may be related to infection are seizures, irritability and 
changes in the level of consciousness. CT brain can 
reveal ventricular dilatation. The disconnections thro-
ughout the system, highlighted by radiographs of the 
path of the catheter.
17
 Patients with suspected malfunc-
tion, or abdominal pain should be submitted to ultra-
sound to outline collections in abdominal cavity.
18
 
CSF, Shunt tube, Blood Serum are collected and sent 
for Culture and sensitivity. 
 Shunt infection is treated by removing the shunt or 
distal end exteriorization and vancomycin and a third 
or fourth generation cephalosporin for 3 – 4 weeks and 
sub-sequent relocation of the shunt system after nega-
tive C&S.
19,20
 Previous studies have evaluated shunt – 
associated infections predominantly in the pediatric 
population, and only limited data are published about 
infection in adults.
21,22
 We performed a retrospective 
analysis of consecutive episodes of CSF shunt related 
infection among both adult and pediatric population, to 
determine the microbiological characteristics of shunt 
associated infections and treatment. 
 
MATERIALS AND METHODS 
This Retrospective study was carried out in the Depar-
tment of Neurosurgery Lady Reading Hospital Pesha-
war, from Jan 2012 to Dec 2013 (one year). The medi-
cal record of all cases operated in last one year was 
checked from record room. Documentation was done 
according to Performa designed indicating age, sex, 
clinical features, investigations with findings on X-
rays, Cause of hydrocephalus, CT, MRI in specific 
cases where needed, CSF culture and sensitivity, shunt 
tube C&S where needed, and serum C&S. All patients 
of either sex and age with Previous Ventriculoperito-
neal shunt surgery and Signs and symptoms suggestive 
of shunt related infection were included in the study. 
While patients with no History of shunt infection were 
excluded from the study. All patients were admitted 
through casualty. All patients were subjected to detail 
history, examination, Neuro-imaging like CT brain, 
MRI brain in specific cases, CSF culture and sensiti-
vity, shunt tubes C&S. Shunt tube lower end was Exte-
riorized or removed. Patients were put on empirical 
therapy, Vancomycin and third generation cephalo-
sporin and later on converted according to C&S. 
Meanwhile EVD was put in (as in adults or children 
when fontanels closed) or Ventricular taping if fonta-
nels open in children. When 2 consecutive C&S were 
negative, again shunt was put in. all patients dischar-
ged on 4th postoperative day, when the patients were 
stable. Patient follow-up as per medical record che-
cked after 1 month, 3 months, 6 months and 1 year. 
All the Data was put in preformed Proforma and data 
was analyzed using SPSS software version 20. 
 
RESULTS 
Total 82 patients were included in the study in which 
males were 50 (60.97%) while females were 32 
(39.02%). All the patients were in the age range of 6 
months to 75 years having mean age of 37.75 years ± 
5 SD. 58 (70.73%) were in pediatric age group and 24 
(29.26%) were adults. Regarding etiology congenital 
acqueductal stenosis was the leading cause in chil-
dren‟s having 22/58 (37.93%), myelomeningoceole in 
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Fig. 1:  Gender Distribution of Patients N = 82. 
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20 (34.48%), CNS tumors in 10 (17.24%), post infec-
tious in 3 (5.17%) and post hemorrhagic in 3 (5.17%). 
CNS tumors were the most common cause in adults 
having 10/24 (41.66%), Sub arachnoid hemorrhage in 
4 (16.66%), Trauma in 3 (12.5%), Normal pressure 
hydrocephalus in 4 (16.66%), post TBM in 2 (8.33%) 
and unknown in 1 (4.16%). Fever and vomiting were 
the most common mode of presentation with 66 (80%) 
cases, altered sensorium in 10 (12.19%), seizures in 20 
(25%), and abdominal tenderness in 3.6%. overall 
 
Table 1:  Age Wise Distribution of Patients N = 82. 
 
Age of the 
Patients 
No of Patients 
Percentage of 
Patients 
< 1 year 20 24.39% 
1 to 14 years  38 46.34 % 
15 to 45 years  14 17.07% 
> 45 years  10 12.19% 
 
Table 2: Etiology of Hydrocephalus in Children’s 
N = 82. 
 
Etiology 
No of 
Patients 
Percentage of 
Patients 
Congenital acquiductal 
stenosis 
22 37.93% 
Post hemorrhagic   3   5.17% 
Post myelomeningoceole 20 34.48 % 
Post infection   3   5.17% 
CNS tumors 10 17.24% 
 
incidence of shunt infection was 12 (14.63%) in which 
the most common microorganism was coagulase nega-
tive staphylococci having 6/12 (50%) cases, Staphy-
lococcus aureus in 2 (16.46%), Streptococcus epi-
dermidus in 2 (16.46%), klebsiella pneumonia in 1 
(8.33%), and polymicrobial in 1 (8.33%). Of the infe-
cted 12 cases 8 (66.66%) were in pediatric age group 
and 4 (33.33%) were adults. All the patients were re 
operated for VP shunting after 2 consecutive C&S 
were negative. Majority 7 (58.33%) patients had shunt 
infection in first month of surgery, while 2 (16.66%) in 
first 3 months, 2 (16.66%) in 6 months and 1 (8.33) in 
1 year. Medical records of patients follow up was che-
cked, and patients were followed for shunt reinsertion 
after, 1 month, 3 months, 6 months and 1 year. 
 
Table 3: Signs and Symptoms in Shunt Infection Pat-
ients N = 12. 
 
Signs and Symptoms 
No. of 
Patients 
Percentage of 
Patients 
Fever 6 50% 
Vomiting  2 16.66% 
Altered sensorium  2 16.66% 
Abdominal tenderness 1 8.33% 
Seizures 1 8.33% 
 
Table 4: Frequency of Causative Microorganisms in 
Infected Shunts N = 12. 
 
Causative Organisms 
No of 
Patients 
Percentage 
of Patients 
Coagulase negative 
staphylococci 
6 50% 
Staphylococcal aureus  2 16.66% 
Streptococcus epidermidus 2 16.66% 
Klebseilla pneumonia 1 8.33% 
Polymicrobial 1 8.33% 
 
DISCUSSION 
Most published studies of CSF shunt related infections 
have involved the pediatric population.
23,24
 In the pre-
sent study, we investigated both pediatric and adult 
patients of shunt – associated infection. Shunt infect-
ion is a very morbid complication of ventriculoperi-
toneal shunting. Various methods have been tried with 
variable success. Meticulous aseptic techniques pre-
operatively and intraoperatively is essential in prevent-
ing bacterial colonization.
25
 Infections following VP 
shunt procedure can cause catheter blockage compli-
cating the results of surgery and are associated with 
high morbidity and mortality.
26
 Colonized shunts do 
not function well mechanically.
27
 In our study we had 
58 (70.73%) pediatric patients with VP shunt and 
adults 24 (29.26%). So hydrocephalus more common 
in pediatric population as compared to adults in our 
study. We had congenital aqueductal stenosis most 
common cause of hydrocephalus in 22 (37.93%) in
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Fig. 2:  Etiology of Hydrocephalus in Adults N = 82. 
 
children which had more chance of infection in 5 
(22.72%). Our results are comparable study conducted 
by Stephen C etal
28 
who reported 23% shunt infection 
in patients with hydrocephalus due to aqueductal ste-
nosis. We had evaluated shunt infected in 12 patients 
so incidence of infection is 14.63% which is consistent 
with accepted rates of pediatric VP shunt infection at 
other institutions.
29
 However, the incidence of infect-
ion in shunted patients with hydrocephalus has wide 
variation, ranging from 1.5% – 69%.30,31 But in a rec-
ent study in our country the rate of shunt infections 
was reported to be 14.5%,
32
 which is very close to our 
results. We had shunt infection more in pediatric popu-
lation in 8 (66.66%) as compared to adult population 
in 4 (33.33%). Ersahin et al, reviewed the charts of 
306 patients undergoing 612 shunt procedure and fou-
nd that patients under 1 year and patients with multiple 
revisions were at increased risk for infection.
33
 So his 
results are consistent with our results except he revie-
wed large sample size. Shunt infection is more in pedi-
atric age. We found coagulase negative staphylococci 
most common organisms 6 (50%) causing shunt infec-
tion, followed by Staph aureus and Streptococcus 
epidermidis. which is comparable to international stu-
dy in which coagulase negative staphylococci cause 36 
to 80% of shunt infection.
34,35
 In gram positive shunt 
infections, majority of the organisms are commensals 
of the skin, a result of direct wound contamination 
during surgery.
36
 Although gram negative bacterial 
colonization of the skin is not common, they could 
probably be introduced during surgery. Another pro-
bable mechanism is „retrograde‟ infection, in which an 
asymptomatic perforation of the bowel leads to distal 
contamination of the VP shunt catheter and retrograde 
progression of infection.
37
 In another international 
study The organisms most frequently causing infect-
ions of indwelling ventricular catheter are the coagu-
lase – negative staphylococci. The second most fre-
quent pathogen is S. aureus
38-41
 which is comparable to 
our study. 
 
CONCLUSION 
Shunt infection most commonly occur in children‟s 
and coagulase negative staphylococci is the most com-
mon causative organism. 
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